The Combinostics cNeuro™ platform combines the company’s innovative AI technology with a holistic view of patient data (imaging biomarkers, demographic and clinical data, neuropsychology test results, and other biomarkers) to enable clinicians to make reliable, evidence-based diagnostic and management decisions for their patients with neurological disorders.
Location: Finland, West Finland, Tampere
Employees: 11-50
Phone: +46 73 069 90 57
Total raised: $4.3M
Founded date: 2014
Investors 2
| Date | Name | Website |
| - | NordicNinj... | nordicninj... |
| - | MassChalle... | masschalle... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 22.11.2019 | Series A | $4.3M | - | finsmes.co... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 22.11.2019 | Combinostics Raises €3.9M in Series A Funding | Combinostics, a Tampere, Finland-based health tech company, closed a €3.9M Series A funding round. ... | finsmes.co... |
| 21.11.2019 | Finland-based startup Combinostics raises $4.3M to support e... | There are no effective treatments for neurodegenerative diseases like Alzheimer’s, but early-stage d... | techstartu... |
| 21.11.2019 | Top tech startup news for today, Thursday, November 21, 2019... | Good morning! Below are some of the top tech startup news for today, Thursday, November 21, 2019. E... | techstartu... |
| 13.03.2017 | Leo Innovation Lab invests $5.5M in five startups to drive d... | Copenhagen, Denmark-based Leo Innovation Lab announced a $5.5 million Series A and seed funding roun... | mobihealth... |
| 10.03.2017 | LEO Innovation Lab invests $5.5 million in healthtech | Healthtech in the U.S. far exceeds advancements made in Europe, according to the CEO of LEO iLAB Ed... | vator.tv/n... |